WINDTREE THERAPEUTICS Business Summary

Windtree Therapeutics Inc. (WINT) operates as a diversified holding company that has strategically pivoted from a pure-play clinical-stage biotechnology firm to a multi-segment revenue model. The company generates revenue through three primary channels: licensing royalties from its acute pulmonary franchise (including AEROSURF and SURFAXIN), milestone payments from the sale of its cardiovascular pipeline to Seismic Pharmaceutical Holdings (retaining a 20% interest in future proceeds), and its newly established fintech division following the late 2025 acquisition of CommLoan, Inc. This fintech segment utilizes the proprietary CUPID platform to facilitate commercial real estate lending. Additionally, Windtree has pioneered a digital asset treasury strategy, securing up to $520 million in funding from Build & Build Corp to maintain direct exposure to the BNB cryptocurrency ecosystem. Positioned as a micro-cap turnaround play, Windtree competes with other specialized biopharmaceutical and diversified medical firms such as HCW Biologics, ZyVersa Therapeutics, and Clearmind Medicine, distinguishing itself through its aggressive integration of digital assets and financial technology into a traditional life sciences framework. Originally founded in 1992 as Discovery Laboratories, the company is currently led by President and CEO Jed Latkin, who assumed the role in December 2024. Latkin brings nearly 30 years of experience in biotech and investment banking, having previously served as CEO of Navidea Biopharmaceuticals and COO of ProPhase Labs. The executive team includes Senior VP and CFO Jamie McAndrew and VP of Technical Operations George Cox, a veteran who has managed the company’s global manufacturing and logistics since 2008. Following the January 2026 resignation of former COO Eric L. Curtis, the company’s strategic direction is heavily influenced by a board chaired by former CEO Craig Fraser and featuring Lead Independent Director Mark Strobeck. Notable institutional backing and strategic guidance are provided by Build & Build Corp, led by digital asset specialist Patrick Horsman, and the investment group Seven Knots, LLC.